Terumo Corp  

(Public, TYO:4543)   Watch this stock  
Find more results for 4543
31,950,000.00
+31,946,684.00 (963,700.88%)
Delayed:   11:13AM GMT+9
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 31,950,000.00 - 33,000,000.00
52 week 2,328.00 - 33,000,000.00
Open 33,000,000.00
Vol. 361,400.00
Mkt cap 1.24T
P/E 281,340.16
Div/yield 16.00/0.00
EPS 113.56
Shares 378.83M
Beta     -
Inst. own     -
Nov 2, 2015
Q2 2016 Terumo Corp Earnings Presentation (Japanese) (Estimated) Add to calendar
Nov 2, 2015
Q2 2016 Terumo Corp Earnings Release (Estimated) Add to calendar
Aug 4, 2015
Q1 2016 Terumo Corp Earnings Call
Aug 4, 2015
Q1 2016 Terumo Corp Earnings Call (Japanese)
Aug 4, 2015
Q1 2016 Terumo Corp Earnings Release
Jun 24, 2015
Terumo Corp Annual Shareholders Meeting
Jun 24, 2015
Terumo Corp Annual Shareholders Meeting (Estimated)
  

Key stats and ratios

Q2 (Jun '15) 2015
Net profit margin 11.27% 7.86%
Operating margin 14.84% 12.23%
EBITD margin - 22.09%
Return on average assets 5.89% 4.22%
Return on average equity 10.02% 7.19%
Employees 19,934 -
CDP Score - 11

Address

2-44-1, Hatagaya
SHIBUYA-KU, TKY 151-0072
Japan
+81-3-33748111 (Phone)
+81-3-33748399 (Fax)

Website links

External links

Description

TERUMO CORPORATION is manufacturer of medical supplies. The Hospital Products segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The Cardiac and Vascular Area segment is involved in the manufacture, purchase and sale of catheter systems, artificial heart and lungs, as well as artificial blood vessels, the manufacture and sale of therapeutic coils for cerebral aneurysm, sampling equipment and kits for platelet-rich plasma and concentrated bone-marrow cell, and large-bore sheaths. The Blood System segment is engaged in the manufacture, purchase and sale of blood transfusion-related products. It also manufactures and sells healthcare related products. As of March 31, 2013, the Company had 79 subsidiaries and 2 associated companies.

Officers and directors

Koji Nakao Chairman of the Board, Representative Director
Age: 68
Yutaro Shintaku President, Representative Director
Age: 59
Ryo Nishihata Senior Executive Officer, Director of Finance
Hiroshi Matsumura Executive Vice President, President of Hospital Company, Director
Age: 61
Takayoshi Mimura Senior Managing Executive Officer, Chairman & General Manager of Subsidiary, Director
Age: 61
Akira Oguma Senior Managing Executive Officer, Director
Age: 62
Shoji Hatano Managing Executive Officer, Manager of Business Planning Office, Leader of Business Planning Group in Business Planning Office
Narushige Toda Senior Executive Officer, Director of Domestic Sales in Hospital Company
Hideo Arase Senior Executive Officer, President & Chief Executive Officer of Subsidiary, Director
Age: 60
David Perez Senior Executive Officer, President of Blood System Company, President & Chief Executive Officer of Subsidiary, Director
Age: 55